After 21 years of living and working in the UK, in October 2022, Emerald’s founder, Elizabeth Crocker, brought her knowledge and expertise back home to the United States. Emerald Venture Partners Limited provided its expertise across the healthcare spectrum of science and technology in the United Kingdom and Europe.
Elizabeth incorporated Emerald Venture Partners Inc in Kansas, with Brent Cliveden, an international bioscience/pharma colleague. The Kansas City Metro Area is at the center of explosive innovation in bioscience and digital health in America’s heartland. New companies are rapidly emerging and supported by business mentors, expert consultants, and a sustainable investor community.